BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9177467)

  • 1. Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cells.
    Renner C; Held G; Ohnesorge S; Bauer S; Gerlach K; Pfitzenmeier JP; Pfreundschuh M
    Cancer Immunol Immunother; 1997 Apr; 44(2):70-6. PubMed ID: 9177467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of naive and memory T cells in tumor cell lysis mediated by bi-specific antibodies.
    Renner C; Held G; Ohnesorge S; Bauer S; Gerlach K; Pfitzenmeier JP; Pfreundschuh M
    Immunobiology; 1997 Jun; 197(1):122-32. PubMed ID: 9241536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
    Musgrave BL; Watson CL; Hoskin DW
    J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do cytotoxic lymphocytes kill their targets?
    Shresta S; Pham CT; Thomas DA; Graubert TA; Ley TJ
    Curr Opin Immunol; 1998 Oct; 10(5):581-7. PubMed ID: 9794837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes.
    Sobek V; Balkow S; Körner H; Simon MM
    Eur J Immunol; 2002 Sep; 32(9):2490-9. PubMed ID: 12207333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide.
    Ohminami H; Yasukawa M; Kaneko S; Yakushijin Y; Abe Y; Kasahara Y; Ishida Y; Fujita S
    Blood; 1999 Feb; 93(3):925-35. PubMed ID: 9920842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
    Zhang F; Chu X; Wang L; Zhu Y; Li L; Ma D; Peng J; Hou M
    Eur J Haematol; 2006 May; 76(5):427-31. PubMed ID: 16480433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
    Lancki DW; Hsieh CS; Fitch FW
    J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
    Yang S; Haluska FG
    J Immunol; 2004 Apr; 172(7):4599-608. PubMed ID: 15034078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent.
    Gruen M; Bommert K; Bargou RC
    Cancer Immunol Immunother; 2004 Jul; 53(7):625-32. PubMed ID: 15175907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.
    Yasukawa M; Ohminami H; Arai J; Kasahara Y; Ishida Y; Fujita S
    Blood; 2000 Apr; 95(7):2352-5. PubMed ID: 10733506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage.
    Grujic M; Braga T; Lukinius A; Eloranta ML; Knight SD; Pejler G; Abrink M
    J Biol Chem; 2005 Sep; 280(39):33411-8. PubMed ID: 16046402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+ signaling modulates cytolytic T lymphocyte effector functions.
    Esser MT; Haverstick DM; Fuller CL; Gullo CA; Braciale VL
    J Exp Med; 1998 Apr; 187(7):1057-67. PubMed ID: 9529322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B.
    Trapani JA
    Aust N Z J Med; 1995 Dec; 25(6):793-9. PubMed ID: 8770355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis.
    Simon MM; Waring P; Lobigs M; Nil A; Tran T; Hla RT; Chin S; Müllbacher A
    J Immunol; 2000 Oct; 165(7):3663-72. PubMed ID: 11034370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.
    Melgar S; Bas A; Hammarström S; Hammarström ML
    Immunology; 2002 Aug; 106(4):476-85. PubMed ID: 12153510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of human tumors with T-cell-activating bispecific antibodies: stimulation of cytotoxic pathways in vivo.
    Bauer S; Renner C; Juwana JP; Held G; Ohnesorge S; Gerlach K; Pfreundschuh M
    Cancer Res; 1999 Apr; 59(8):1961-5. PubMed ID: 10213507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell death induction by CTL: perforin/granzyme B system dominantly acts for cell death induction in human hepatocellular carcinoma cells.
    Hayashida M; Kawano H; Nakano T; Shiraki K; Suzuki A
    Proc Soc Exp Biol Med; 2000 Nov; 225(2):143-50. PubMed ID: 11044257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
    Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
    J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.